In the quiet corridors of Poland’s public hospitals, a growing crisis is unfolding—not in the operating rooms or intensive care wards, but in the reception areas where patients are now being handed ringing telephones and told, in strained voices, that their long-awaited MRI or CT scan has been postponed—again.
This isn’t merely a logistical hiccup. It’s a symptom of a deeper, systemic strain within Poland’s healthcare financing model, one that has been quietly fraying at the seams for over a decade. As diagnostic delays mount and hospital administrators warn of mounting arrears, the human cost is being measured not just in prolonged anxiety, but in eroded trust in a system once heralded as a pillar of post-communist social solidarity.
The immediate trigger, as reported by WP Wiadomości, is a decision by the National Health Fund (Narodowy Fundusz Zdrowia, or NFZ) to impose stricter limits on reimbursable diagnostic imaging procedures—particularly those involving ionizing radiation like CT scans—citing concerns over overuse and patient safety. Hospital directors, though, counter that these restrictions are less about clinical prudence and more about fiscal triage: the NFZ is running dangerously low on funds, and limiting expensive tests is seen as a way to stave off insolvency.
But here’s what the initial reports didn’t fully convey: this isn’t just about today’s budget shortfall. It’s the culmination of a structural mismatch between Poland’s aging demographic, the rapid advancement of medical technology, and a healthcare funding mechanism that has not kept pace with either.
Consider the numbers: Poland has one of the fastest-aging populations in the European Union. By 2030, nearly 25% of Poles will be over 65, up from 18% in 2020, according to Eurostat. Older patients require significantly more diagnostic imaging—CT scans for cancer staging, MRIs for neurological assessment, ultrasounds for cardiovascular monitoring—yet the NFZ’s annual budget for outpatient diagnostics has grown by less than 2% per year since 2018, while the cost of a single modern MRI scan has risen by over 40% in the same period due to helium prices, software licensing, and maintenance contracts.
Meanwhile, Poland’s diagnostic capacity remains starkly uneven. While Warsaw and Kraków boast high-end imaging centers with AI-assisted radiology workflows, many eastern voivodeships—Podlasie, Lublin, Subcarpathia—still rely on equipment that is, on average, over ten years old. A 2023 audit by the Supreme Audit Office (Najwyższa Izba Kontroli) found that 38% of public hospital MRI machines were past their recommended lifespan, increasing the risk of breakdowns and diagnostic errors.
“We’re not refusing scans because we think patients don’t need them,” said Dr. Ewa Kowalska, head of radiology at the Provincial Hospital in Białystok, in a recent interview with Polsat News. “We’re refusing them because the NFZ won’t pay for them after March, and One can’t keep eating the losses. Every unsanctioned scan puts us deeper into debt—and eventually, someone has to pay the bill. Right now, it’s falling on the hospitals.”
Her sentiment echoes a growing consensus among healthcare economists. “Poland’s system is caught in a classic ‘cost disease’ trap,” explained Professor Marcin Włoszczak of the Warsaw School of Economics, whose research focuses on healthcare financing in Central Europe. “Labor-intensive services like diagnostics can’t absorb productivity gains the way manufacturing or IT can. Yet we fund them through a fixed-budget model that assumes zero inflation in medical costs. It’s mathematically unsustainable.”
The ripple effects extend beyond patient frustration. Delayed diagnostics mean later-stage cancer diagnoses, which are not only more traumatic for patients but significantly more expensive to treat. A study published in the European Journal of Cancer Care last year estimated that a three-month delay in lung cancer diagnosis increases treatment costs by an average of 42% and reduces five-year survival rates by nearly 18 percentage points.
the burden is shifting. Patients who can afford it are increasingly turning to private clinics—where a private MRI in Poznań now costs between 800 and 1,200 złoty, roughly a quarter of the average monthly wage. This creates a two-tier system: those with means get timely care; those without wait, worry, and sometimes deteriorate.
The NFZ maintains that its restrictions are evidence-based. In a statement to PAP, the Fund cited guidelines from the International Commission on Radiological Protection, arguing that unnecessary exposure to radiation—even low-dose—carries cumulative risks, particularly for younger patients. “We are not cutting care,” an NFZ spokesperson insisted. “We are optimizing it.”
But critics argue that the real optimization is happening on the balance sheet, not the patient chart. “When you limit access to diagnostics under the banner of radiation safety while simultaneously underfunding preventive oncology and smoking cessation programs,” noted Katarzyna Lewandowska, a health policy analyst with the Institute of Patient Rights and Health Education, “you’re not practicing radioprotection—you’re practicing rationing by attrition.”
There are precedents for this kind of pressure point. In 2015, Greece’s public healthcare system faced near-collapse during the sovereign debt crisis, leading to similar restrictions on diagnostics and pharmaceuticals. Recovery came only after structural reforms, EU-backed investment in health infrastructure, and a shift toward outcome-based funding. Poland, while not in crisis of that magnitude, is flirting with a similar path—one where short-term fiscal fixes undermine long-term public health resilience.
The solution, experts suggest, lies not in cutting corners but in rethinking the funding architecture. Pilots in regions like Greater Poland have shown promise with bundled payments for diagnostic pathways—paying a fixed fee for a complete workup (e.g., for suspected stroke) rather than per procedure—reducing redundancy while ensuring timely access. Others advocate for a diagnostic equity fund, financed through a little levy on private imaging services, to subsidize high-cost scans in underserved areas.
For now, however, the phones keep ringing. And with each call, a patient hears not just silence on the other end, but the quiet unraveling of a promise: that in Poland, no one should have to choose between their health and their financial survival.
What does it say about a society when the sound of a hospital telephone becomes a source of dread rather than hope? And more urgently—what are we willing to do to change that tone?
